Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, especially for cancers where remedy possibilities remain limited. Make use of the links below to learn a lot more about our portfolio of cytokine-based immunotherapy candidates. https://financefeeds.com/meta-cro-john-hegeman-joins-robinhood-board-of-directors/